生物衰老的主要分子机制概述

doi:10.19586/j.2095-2341.2022.0170

生物技术进展 ›› 2023, Vol. 13 ›› Issue (2): 228-233.DOI: 10.19586/j.2095-2341.2022.0170

• 进展评述 • 上一篇

生物衰老的主要分子机制概述

张维(), 王红芳, 胥保华()

山东农业大学动物科技学院，山东泰安 271018

收稿日期:2022-10-21 接受日期:2023-01-12 出版日期:2023-03-25 发布日期:2023-04-07
通讯作者: 胥保华
作者简介:张维 E-mail: zw15369312856@163.com;
基金资助:
国家自然科学基金项目(32272937);国家自然科学基金青年项目(32102607)

Overview of the Main Molecular Mechanisms of Biological Aging

Wei ZHANG(), Hongfang WANG, Baohua XU()

College of Animal Science and Technology，Shandong Agricultural University，Shandong Taian 271018，China

Received:2022-10-21 Accepted:2023-01-12 Online:2023-03-25 Published:2023-04-07
Contact: Baohua XU

摘要/Abstract

摘要：

衰老是一种包括生理性衰老和病理性衰老的正常自然规律，与其他生物过程一样，受一些信号通路和分子机制的调控。研究发现调控生物衰老机制的信号通路之间存在相互作用。综述了胰岛素通路、雷帕霉素通路及Sirtuins家族这3种与自噬相关的延缓衰老的经典信号通路，总结了氧化应激、细胞衰老、免疫衰老等影响机体衰老的主要原因及方式，希望在此基础上发现新的互作通路，探索出更多新颖的分子机制和方法以预防、延缓或减轻多种与衰老相关的疾病。

关键词: 衰老, 信号通路, 分子机制

Abstract:

Aging is a normal natural law including physical aging and pathological aging. Like other biological processes， it is regulated by some signaling pathways and molecular mechanisms. Through the research on the mechanism of regulating biological aging， it is found that the signaling pathways interact with each other. This paper reviewed three classical signal pathways related to autophagy and delaying aging， including insulin pathway， rapamycin pathway and Sirtuins family， and summarized the main causes and ways of oxidative stress， cell aging and immune aging affecting aging， hoping to discover new interaction pathways and explore more novel molecular mechanisms and methods to prevent， delay or reduce a variety of diseases related to aging.

Key words: aging, signaling pathway, molecular mechanism

中图分类号:

Q419

张维, 王红芳, 胥保华. 生物衰老的主要分子机制概述[J]. 生物技术进展, 2023, 13(2): 228-233.

Wei ZHANG, Hongfang WANG, Baohua XU. Overview of the Main Molecular Mechanisms of Biological Aging[J]. Current Biotechnology, 2023, 13(2): 228-233.

参考文献 64

1	GAO C, LI Q, YU J, et al.. Endocrine pheromones couple fat rationing to dauer diapause through HNF4α nuclear receptors[J]. Sci. China Life Sci., 2021, 64(12): 2153-2174.
2	CAMPISI J, KAPAHI P, LITHGOW G J, et al.. From discoveries in ageing research to therapeutics for healthy ageing[J]. Nature, 2019, 571(7764): 183-192.
3	MCCAY C M, MAYNARD L A, SPERLING G, et al.. Retarded growth, life span, ultimate body size and age changes in the albino rat after feeding diets restricted in calories[J]. Nutr. Rev., 1975, 33(8): 241-243.
4	RUSSO G L, SPAGNUOLO C, RUSSO M, et al.. Mechanisms of aging and potential role of selected polyphenols in extending healthspan[J/OL]. Biochem. Pharmacol., 2020, 173: 113719[2022-08-23]. .
5	GUARENTE L, KENYON C. Genetic pathways that regulate ageing in model organisms[J]. Nature, 2000, 408(6809): 255-262.
6	LONGO V D, FINCH C E. Evolutionary medicine: from dwarf model systems to healthy centenarians[J]. Science, 2003, 299(5611): 1342-1346.
7	TATAR M, BARTKE A, ANTEBI A. The endocrine regulation of aging by insulin-like signals[J]. Science, 2003, 299(5611): 1346-1351.
8	KIM S S, LEE C K. Growth signaling and longevity in mouse models[J]. BMB Rep., 2019, 52(1): 70-85.
9	FRIEDMAN D B, JOHNSON T E. A mutation in the age-1 gene in Caenorhabditis elegans lengthens life and reduces hermaphrodite fertility[J]. Genetics, 1988, 118(1): 75-86.
10	KENYON C, CHANG J, GENSCH E, et al.. A C. elegans mutant that lives twice as long as wild type[J]. Nature, 1993, 366(6454): 461-464.
11	KLASS M R. A method for the isolation of longevity mutants in the nematode Caenorhabditis elegans and initial results[J]. Mech. Ageing Dev., 1983, 22(3-4): 279-286.
12	CORDEIRO L M, MACHADO M L, SILVA F D A, et al.. Rutin protects Huntington's disease through the insulin/IGF1(IIS) signaling pathway and autophagy activity: study in Caenorhabditis elegans model[J/OL]. Food Chem. Toxicol., 2020, 141: 111323[2022-09-01]. .
13	KENYON C J. The genetics of ageing[J]. Nature, 2010, 464(7288): 504-512.
14	VEECH R L, BRADSHAW P C, CLARKE K, et al.. Ketone bodies mimic the life span extending properties of caloric restriction[J]. IUBMB Life, 2017, 69(5): 305-314.
15	KAPAHI P, ZID B M, HARPER T, et al.. Regulation of lifespan in Drosophila by modulation of genes in the TOR signaling pathway[J]. Curr. Biol., 2004, 14(10): 885-890.
16	KAEBERLEIN M, POWERS R W, STEFFEN K K, et al.. Regulation of yeast replicative life span by TOR and Sch9 in response to nutrients[J]. Science, 2005, 310(5751): 1193-1196.
17	CAPRI M, SANTORO A, GARAGNANI P, et al.. Genes of human longevity: an endless quest[J]. Curr. Vasc. Pharmacol., 2014, 12 (5): 707-717.
18	LIU G Y, SABATINI D M. mTOR at the nexus of nutrition, growth, ageing and disease[J]. Nat. Rev. Mol Cell Biol., 2020, 21 (4): 183-203.
19	JIA K, CHEN D, RIDDLE D L. The TOR pathway interacts with the insulin signaling pathway to regulate C. elegans larval development, metabolism and life span[J]. Development, 2004, 131(16):3897-3906.
20	VELLAI T, TAKACS-VELLAI K, ZHANG Y, et al.. Genetics: influence of TOR kinase on lifespan in C . elegans[J/OL]. Nature, 2003, 426(6967): 620[2022-09-01]. .
21	SAXTON R A, SABATINI D M. mTOR signaling in growth, metabolism, and disease[J]. Cell, 2017, 169(2): 361-371.
22	RUSSELL R C, YUAN H X, GUAN K L. Autophagy regulation by nutrient signaling[J]. Cell Res., 2014, 24(1): 42-57.
23	ANTIKAINEN H, DRISCOLL M, HASPEL G, et al.. TOR-mediated regulation of metabolism in aging[J]. Aging Cell, 2017, 16(6): 1219-1233.
24	WANG L, DU J, ZHAO F, et al.. Trillium tschonoskii maxim saponin mitigates D-galactose-induced brain aging of rats through rescuing dysfunctional autophagy mediated by Rheb-mTOR signal pathway[J]. Biomed. Pharmacother., 2018, 98: 516-522.
25	KENNEDY B K, LAMMING D W. The mechanistic target of rapamycin: the grand conducTOR of metabolism and aging[J]. Cell Metab., 2016, 23(6): 990-1003.
26	VASSILOPOULOS A, FRITZ K S, PETERSEN D R, et al.. The human sirtuin family: evolutionary divergences and functions[J]. Hum. Genom., 2011, 5(5): 485-496.
27	VAN DEVEN R A H, SANTOS D, HAIGIS M C. Mitochondrial Sirtuins and molecular mechanisms of aging[J]. Trends Mol. Med., 2017, 23(4): 320-331.
28	FANG E F, LAUTRUP S, HOU Y, et al.. NAD(+) in aging: molecular mechanisms and translational implications[J]. Trends Mol. Med., 2017, 23(10): 899-916.
29	SATOH A, BRACE C S, RENSING N, et al.. Sirt1 extends life span and delays aging in mice through the regulation of Nk2 homeobox1 in the DMH and LH[J]. Cell Metab., 2013, 18(3): 416-430.
30	KENYON C. The plasticity of aging: insights from long-lived mutants[J]. Cell, 2005, 120(4): 449-460.
31	BERDICHEVSKY A, VISWANATHAN M, HORVITZ H R, et al.. C. elegans SIR-2.1 interacts with 14-3-3 proteins to activate DAF-16 and extend life span[J]. Cell, 2006, 125(6): 1165-1177.
32	HEIDLER T, HARTWIG K, DANIEL H, et al.. Caenorhabditis elegans lifespan extension caused by treatment with an orally active ROS-generator is dependent on DAF-16 and SIR-2.1[J]. Biogerontology, 2010, 11(2): 183-195.
33	ALMEIDA M, PORTER R M. Sirtuins and FoxOs in osteoporosis and osteoarthritis[J]. Bone, 2019, 121: 284-292.
34	PEARSON K J, BAYR J A, LEWIS K N, et al.. Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span[J]. Cell Metab., 2008, 8(2): 157-168.
35	HARMAN D. Aging: a theory based on free radical and radiation chemistry[J]. J. Gerontol., 1956, 11(3): 298-300.
36	SARGIS R M, SUBBAIAH P V. Protection of membrane cholesterol by sphingomyelin against free radical-mediated oxidation[J]. Free Radic. Biol. Med., 2006, 40(12): 2092-2102.
37	WALLACE D C. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine[J]. Annu. Rev. Genet., 2005,39: 359-407.
38	陈瑗,周玫,刘尚喜,等.营养、衰老与自由基理论[J].营养学报,2005(3): 177-180.
39	杨茂林,孟思进.线粒体氧化损伤在衰老发生机制中的作用[J].医学综述,2010,16(9):1297-1300.
40	KUJOTH G C, HIONA A, PUGH T D, et al.. Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging[J]. Science, 2005, 309(5733): 481-484.
41	TRIFUNOVIC A, HANSSON A, WREDENBERG A, et al.. Somatic mtDNA mutations cause aging phenotypes without affecting reactive oxygen species production[J]. Proc. Natl. Acad. Sci. USA, 2005, 102(50): 17993-17998.
42	MIKULA-PIETRASIK J, NIKLAS A, URUSKI P, et al.. Mechanisms and significance of therapy-induced and spontaneous senescence of cancer cells[J]. Cell Mol. Life Sci., 2020, 77(2): 213-229.
43	GORGOULIS V, ADAMS P D, ALIMONTI A, et al.. Cellular senescence: defining a path forward[J]. Cell, 2019, 179(4): 813-827.
44	薛嘉,谢晓刚,康健,等.通过自噬调控细胞衰老的研究进展[J].动物医学进展,2021,42 (1):110-115.
45	BORGHESAN M, HOOGAARS W M H, VARELA-EIRIN M, et al.. A senescence-centric view of aging: implications for longevity and disease[J]. Trends Cell Biol., 2020, 30(10): 777-791.
46	COPPE J P, PATIL C K, RODIER F, et al.. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor[J]. PLoS Biol., 2008, 6(12): 2853-2868.
47	COPPEJP, DESPREZ P Y, KRTOLICA A, et al.. The senescence-associated secretory phenotype: the dark side of tumor suppression[J]. Annu. Rev. Pathol., 2010, 5: 99-118.
48	FRANCESCHI C, CAMPISI J. Chronic inflammation (inflammaging) and its potential contribution to age-associated disease[J]. J. Gerontol. A Biol. Sci. Med. Sci., 2014, 69(S1): S4-S9.
49	LQPEZ-OTIN C, BLASCO M A, PARTRIDGE L, et al.. The hallmarks of aging[J]. Cell, 2013, 153(6): 1194-1217.
50	ACOSTA J C, BANITO A, WUESTEFELD T, et al.. A complex secretory program orchestrated by the inflammasome controls paracrine senescence[J]. Nat. Cell Biol., 2013, 15(8): 978-990.
51	COPPEJP, KAUSER K, CAMPISI J, et al.. Secretion of vascular endothelial growth factor by primary human fibroblasts at senescence[J]. J. Biol. Chem., 2006, 281(40): 29568-19574.
52	TUOMISTO K, JOUSILAHTI P, SUNDVALL J, et al.. C-reactive protein, interleukin-6 and tumor necrosis factor alpha as predictors of incident coronary and cardiovascular events and total mortality. A population-based, prospective study[J]. Thromb. Haemost., 2006, 95(3): 511-518.
53	XU M, PIRTSKHALAVA T, FARR J N, et al.. Senolytics improve physical function and increase lifespan in old age[J]. Nat. Med., 2018, 24(8): 1246-1256.
54	FONTANA L, MITCHELL S E, WANG B, et al.. The effects of graded caloric restriction: XII. comparison of mouse to human impact on cellular senescence in the colon[J/OL]. Aging Cell, 2018, 17(3): e12746[2022-10-10]. .
55	XU C, WANG L, FOZOUNI P, et al.. SIRT1 is downregulated by autophagy in senescence and ageing[J]. Nat. Cell Biol., 2020, 22(10): 1170-1179.
56	NIE D, ZHANG J, ZHOU Y, et al.. Rapamycin treatment of tendon stem/progenitor cells reduces cellular senescence by upregulating autophagy[J/OL]. Stem Cells Int., 2021, 2021: 6638249[2022-10-11]. .
57	BOURGEOIS B, MADL T. Regulation of cellular senescence via the FOXO4-p53 axis[J]. FEBS Lett., 2018, 592(12): 2083-2097.
58	KIM J, AHN D, PARK C J. Biophysical investigation of the dual binding surfaces of human transcription factors FOXO4 and p53[J]. FEBS J., 2022, 289(11): 3163-3182.
59	XU W, WONG G, HWANG Y Y, et al.. The untwining of immunosenescence and aging[J]. Semin Immunopathol., 2020, 42(5): 559-572.
60	ROSTAMZADEH D, YOUSEFI M, HAGHSHENAS M R, et al.. mTOR signaling pathway as a master regulator of memory CD8(+) T-cells, Th17, and NK cells development and their functional properties[J]. J. Cell Physiol., 2019, 234(8): 12353-12368.
61	YOUSEFZADEH M J, FLORES R R, ZHU Y, et al.. An aged immune system drives senescence and ageing of solid organs[J]. Nature, 2021, 594(7861): 100-105.
62	BONAFEM, SABBATINELLI J, OLIVIERI F. Exploiting the telomere machinery to put the brakes on inflamm-aging[J/OL]. Ageing Res. Rev., 2020, 59: 101027[2022-10-10]. .
63	PERRETTI M, D'ACQUISTO F. Novel aspects of annexin 1 and glucocorticoid biology: intersection with nitric oxide and the lipoxin receptor[J]. Inflamm. Allergy Drug Targets., 2006, 5(2): 107-114.
64	MORRISETTE-THOMAS V, COHEN A A, LI Q, et al.. Inflamm-aging does not simply reflect increases in pro-inflammatory markers[J]. Mech. Ageing Dev., 2014, 139: 49-57.

[1]	董立强, 王斌, 苏适, 刘东琦. 雷公藤红素抗肿瘤作用及机制研究进展[J]. 生物技术进展, 2023, 13(1): 77-82.
[2]	高桂珍, 翟云孤, 张鲁斌, 常金梅, 罗海华, 伍晓明. 油菜耐盐碱种质鉴定与品种选育研究进展[J]. 生物技术进展, 2022, 12(5): 647-654.
[3]	徐奔, 覃锐, 向航, 许京淑, 廖子龙, 向金平. 臭椿酮抑制急性骨髓性白血病细胞恶性生物学行为的研究[J]. 生物技术进展, 2022, 12(5): 769-777.
[4]	赵佩, 邹青, 李泽霖. 黄芪甲甙对急性心肌梗死大鼠心室重构和NOX/ROS/TNF⁃α信号通路的影响[J]. 生物技术进展, 2022, 12(5): 778-785.
[5]	陶鸽如, 秦树存. 氢生物医学效应在疏解自由基氧化应激的分子机制[J]. 生物技术进展, 2022, 12(4): 490-496.
[6]	陈晓光, 潘晓峰, 王帆, 潘宋斌. 人参皂苷Rg1对阿尔茨海默症大鼠BDNF⁃TrkB信号通路的影响[J]. 生物技术进展, 2022, 12(3): 446-451.
[7]	黄乔木, 何艳. 雷帕霉素对糖尿病肾病大鼠足细胞生物学行为及mTOR信号通路的影响[J]. 生物技术进展, 2022, 12(3): 460-466.
[8]	李坤, 金丽华. 果蝇造血器官淋巴腺的研究进展[J]. 生物技术进展, 2022, 12(2): 222-228.
[9]	孙卉, 张春义, 姜凌. 辅酶Ⅰ体内代谢调控研究进展[J]. 生物技术进展, 2021, 11(4): 526-534.
[10]	张旭娟,赵鹏翔,YAO Mawulikplimi Adzavon,李秦剑,谢飞. EBV与TLRs信号通路相互作用机制研究进展[J]. 生物技术进展, 2019, 9(3): 231-239.
[11]	YAO Mawulikplimi Adzavon,赵鹏翔,张旭娟,王丽敏,马雪梅. 巨噬细胞迁移抑制因子分子机制研究进展[J]. 生物技术进展, 2018, 8(5): 389-396.
[12]	白志慧,王彦,张日丽,许维恒,张俊平. 秀丽隐杆线虫免疫衰老指标的建立[J]. 生物技术进展, 2017, 7(3): 230-235.
[13]	高丽,谌颜,扈廷茂,李光鹏. 肌肉生长抑制素基因在哺乳动物中的最新研究进展[J]. 生物技术进展, 2014, 4(6): 381-388.
[14]	齐希梁,程红梅. eds1、atr/nrc1、ahl19三个抗病相关的防卫基因的研究进展[J]. 生物技术进展, 2013, 3(4): 238-22.
[15]	赵宏,刘昱辉. 人表皮细胞生长因子及其研究进展[J]. 生物技术进展, 2011, 1(2): 122-129.

生物衰老的主要分子机制概述

Overview of the Main Molecular Mechanisms of Biological Aging

RichHTML

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献 64

相关文章 15

编辑推荐

Metrics

本文评价